EXHIBIT 10.2Registration Rights Agreement • June 4th, 2001 • Lynx Therapeutics Inc • Medicinal chemicals & botanical products • New York
EXHIBIT 10.34 LYNX THERAPEUTICS, INC. LOAN AND SECURITY AGREEMENT This LOAN AND SECURITY AGREEMENT is entered into as of October 23, 2002, by and between COMERICA BANK-CALIFORNIA ("Bank") and LYNX THERAPEUTICS, INC. ("Borrower").Loan and Security Agreement • November 13th, 2002 • Lynx Therapeutics Inc • Medicinal chemicals & botanical products • California
ARTICLE I DEFINITIONSSecurities Purchase Agreement • January 2nd, 2004 • Lynx Therapeutics Inc • Medicinal chemicals & botanical products • New York
ARTICLE.1 PURCHASE AND SALE OF ASSETS........................ 5 ARTICLE.2 CLOSING AND PURCHASE PRICE......................... 6 ARTICLE.3 REPRESENTATIONS AND WARRANTIES OF THE SELLER....... 8 ARTICLE.4 REPRESENTATIONS AND WARRANTIES OF...Asset Purchase Agreement • April 6th, 2004 • Lynx Therapeutics Inc • Medicinal chemicals & botanical products
CONFIDENTIAL SERVICES AGREEMENT This SERVICES AGREEMENT ("Agreement") is made and entered into as of [*] 2003 ("Effective Date"), by and between E.I. du Pont de Nemours and Company, having a principal business address at 1007 Market Street,...Services Agreement • November 13th, 2003 • Lynx Therapeutics Inc • Medicinal chemicals & botanical products • California
RECITALSLicense Agreement • April 11th, 2002 • Lynx Therapeutics Inc • Medicinal chemicals & botanical products • California
NET LEASE BASIC LEASE INFORMATIONLease • May 13th, 1998 • Lynx Therapeutics Inc • Medicinal chemicals & botanical products • California
STOCK PURCHASE AGREEMENT THIS STOCK PURCHASE AGREEMENT is made by and between LYNX THERAPEUTICS, INC., a Delaware corporation (the "Company"), and Edward C. Albini ("Purchaser"). WITNESSETH: WHEREAS, Purchaser holds one stock option to purchase shares...Stock Purchase Agreement • March 30th, 1998 • Lynx Therapeutics Inc • Medicinal chemicals & botanical products • California
EXHIBIT 10.35 COMMON STOCK PURCHASE AGREEMENTCommon Stock Purchase Agreement • March 28th, 2003 • Lynx Therapeutics Inc • Medicinal chemicals & botanical products • California
ARTICLE I DEFINITIONSSecurities Purchase Agreement • March 12th, 2004 • Lynx Therapeutics Inc • Medicinal chemicals & botanical products • New York
ARTICLE II REPRESENTATIONS AND WARRANTIESSecurities Purchase Agreement • June 4th, 2001 • Lynx Therapeutics Inc • Medicinal chemicals & botanical products • New York
EXHIBIT 10.53 LOAN AND SECURITY AGREEMENT THIS LOAN AND SECURITY AGREEMENT (this "Agreement") dated as of December 28, 2004, between SILICON VALLEY BANK, a California chartered bank, with its principal place of business at 3003 Tasman Drive, Santa...Loan and Security Agreement • January 3rd, 2005 • Lynx Therapeutics Inc • Medicinal chemicals & botanical products • Delaware
PART 4 SUBLEASE AND EMPLOYEESAcquisition Agreement • March 24th, 1998 • Lynx Therapeutics Inc • Medicinal chemicals & botanical products • California
EXHIBIT 10.29 JOINT VENTURE AGREEMENT between LYNX Therapeutics Inc., 3832 Bay Center Place, Hayward, California, 94545, USA (hereinafter referred to as "LYNX") and BASF Aktiengesellschaft, 67056 Ludwigshafen, Federal Republic of Germany (hereinafter...Joint Venture Agreement • March 27th, 1997 • Lynx Therapeutics Inc • Medicinal chemicals & botanical products
1 EXHIBIT 10.3 NEITHER THESE SECURITIES NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM...Lynx Therapeutics Inc • June 4th, 2001 • Medicinal chemicals & botanical products
RECITALSSecurities Purchase Agreement • April 30th, 2002 • Lynx Therapeutics Inc • Medicinal chemicals & botanical products • Virginia
EXHIBIT 10.55 WARRANT TO PURCHASE STOCK THIS WARRANT AND THE SHARES ISSUABLE HEREUNDER HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "ACT"), OR THE SECURITIES LAWS OF ANY STATE AND, EXCEPT AND PURSUANT TO THE PROVISIONS OF...Lynx Therapeutics Inc • January 3rd, 2005 • Medicinal chemicals & botanical products • California
SOLEXA LIMITED AND LYNX THERAPEUTICS INC ---------------------------------------- COLONY TECHNOLOGY SHARING AGREEMENT ---------------------------------------- CMS CAMERON MCKENNA MITRE HOUSE 160 ALDERSGATE STREET LONDON EC1A 4DDLynx Therapeutics Inc • October 26th, 2004 • Medicinal chemicals & botanical products
RECITALSIntellectual Property Security Agreement • January 3rd, 2005 • Lynx Therapeutics Inc • Medicinal chemicals & botanical products • California
RECITALSAgreement of Merger • March 27th, 1997 • Lynx Therapeutics Inc • Medicinal chemicals & botanical products • Delaware
BETWEENCollaboration Agreement • September 21st, 2001 • Lynx Therapeutics Inc • Medicinal chemicals & botanical products • California
EMPLOYEE AGREEMENT FOR KATHY A. SAN ROMANEmployee Agreement • May 15th, 2003 • Lynx Therapeutics Inc • Medicinal chemicals & botanical products • California
AGREEMENTRegistration Rights Agreement • April 30th, 2002 • Lynx Therapeutics Inc • Medicinal chemicals & botanical products • Virginia
Exhibit 10.32 Collaboration Agreement dated as of September 30, 1996, by and among the Company and Schwarz Pharma AG CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE...Development and Supply Agreement • November 14th, 1996 • Lynx Therapeutics Inc • Medicinal chemicals & botanical products • New York
ARTICLE.1 PURCHASE AND SALE OF ASSETS................................. 5 ARTICLE.2 CLOSING AND PURCHASE PRICE.................................. 6 ARTICLE.3 REPRESENTATIONS AND WARRANTIES OF THE SELLER................ 8 ARTICLE.4 REPRESENTATIONS AND...Asset Purchase Agreement • May 13th, 2004 • Lynx Therapeutics Inc • Medicinal chemicals & botanical products
EXHIBIT 10.17.1 CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 24B-2 OF THE SECURITIES EXCHANGE ACT OF 1934, AS...Lynx Therapeutics Inc • March 28th, 2003 • Medicinal chemicals & botanical products
EXHIBIT 10.31 CONFIDENTIAL SEPARATION AGREEMENT This Confidential Separation Agreement (the "Agreement") is entered into between Lynx Therapeutics, Inc. (the "Company") and David W. Martin, Jr. ("Dr. Martin"). 1. SEPARATION. Dr. Martin's last day of...Confidential Separation Agreement • March 27th, 1997 • Lynx Therapeutics Inc • Medicinal chemicals & botanical products • California
EXHIBIT 10.13 RESEARCH COLLABORATION AGREEMENTResearch Collaboration Agreement • August 24th, 2001 • Lynx Therapeutics Inc • Medicinal chemicals & botanical products • California
Exhibit 10.12.1 March 1, 2002 Robert T. Giaquinta, Ph.D. Director, Technology Transfer & Licensing DuPont Agriculture & Nutrition Experimental Station P.O. Box 80402 Wilmington, DE 19880 Dear Bob: This letter will serve to confirm and memorialize our...Lynx Therapeutics Inc • May 15th, 2002 • Medicinal chemicals & botanical products
INDEMNITY AGREEMENTIndemnity Agreement • November 13th, 2006 • Solexa, Inc. • Medicinal chemicals & botanical products • Delaware
THIS AGREEMENT is made and entered into as of the 9th day of November, 2006 by and between SOLEXA, INC., a Delaware corporation (the “Corporation”), and ANTHONY SMITH (the “Agent”).
Solexa, Inc. Stock Option Agreement (Incentive Stock Option or Nonstatutory Stock Option)Stock Option Agreement • June 9th, 2005 • Solexa, Inc. • Medicinal chemicals & botanical products
Pursuant to your Stock Option Grant Notice (“Grant Notice”) and this Stock Option Agreement, Solexa, Inc. (the “Company”) has granted you an option under its 2005 Equity Incentive Plan (the “Plan”) to purchase the number of shares of the Company’s Common Stock indicated in your Grant Notice at the exercise price indicated in your Grant Notice. Defined terms not explicitly defined in this Stock Option Agreement but defined in the Plan shall have the same definitions as in the Plan.
RECITALSDevelopment and Services Agreement • May 15th, 2002 • Lynx Therapeutics Inc • Medicinal chemicals & botanical products • California
RECITALSParent Support Agreement • September 30th, 2004 • Lynx Therapeutics Inc • Medicinal chemicals & botanical products • Delaware
SOLEXA, INC. and, , AS WARRANT AGENT FORM OF PREFERRED STOCK WARRANT AGREEMENT DATED AS OFPreferred Stock Warrant Agreement • May 18th, 2006 • Solexa, Inc. • Medicinal chemicals & botanical products • New York
Preferred Stock Warrant Agreement (this “Agreement”), dated as of between Solexa, Inc., a Delaware corporation (the “Company”) and , a [corporation] [national banking association] organized and existing under the laws of and having a corporate trust office in , as warrant agent (the “Warrant Agent”).
SOLEXA, INC. and, ____________, AS WARRANT AGENT FORM OF DEBT SECURITIES WARRANT AGREEMENT DATED AS OF ____________Securities Warrant Agreement • May 18th, 2006 • Solexa, Inc. • Medicinal chemicals & botanical products • New York
Debt Securities Warrant Agreement (this “Agreement”), dated as of between Solexa , Inc., a Delaware corporation (the “Company”) and , a [corporation] [national banking association] organized and existing under the laws of and having a corporate trust office in , as warrant agent (the “Warrant Agent”).
